In melanoma, Wnt5a promotes tumor cell proliferation by activating ADP-ribosylation factor 6 (ARF6) through interaction with FZD4 or LRP6, which in turn facilitates β-catenin nuclear translocation [456]. Here, ARF6 is linked to neoplasm.